[Significance of monomycin concentration in the cerebrospinal fluid in the treatment of experimental purulent meningitis].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000134:cerebrospinal fluid* / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D004285:Dogs; D015643:Erythromycin Ethylsuccinate / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D008581:Meningitis / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D015643:Erythromycin Ethylsuccinate
Znachenie kontsentratsii monomitsina v spinnomozgovoĭ zhidkosti pri lechenii ekspermental'nogo gnoĭnogo meningita.